Form 4: West Pharmaceutical Services Exec Annette Favorite Reports Stock Transactions
SEC Form 4 Filing
Annette Favorite, a Senior VP & Chief HR Officer at West Pharmaceutical Services, reported the acquisition and disposal of company stock and stock options on February 18, 2025.
Summary
- On February 18, 2025, Annette Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services Inc. [WST], reported transactions involving the company's common stock.
- These transactions included the acquisition of 246.162 shares of common stock at a price of $211, and the disposal of 83.794 shares at the same price.
- Following these transactions, Favorite directly owns 6,738.7407 shares of West Pharmaceutical Services Inc.
- Favorite also acquired 1,251 stock options with an exercise price of $211, exercisable beginning February 18, 2026, and expiring on February 18, 2035.
- Additionally, 542 restricted stock units (RSUs) were acquired, vesting in four equal installments beginning on February 18, 2026.
- A power of attorney was granted to Luis Cantarero, Louis Lalli, Ryan Metz and Caitlin Hippeli to handle Section 16(a) filings on Favorite's behalf.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive, which is a routine occurrence. There is no indication of positive or negative implications for the company's performance.
Positives
- The acquisition of stock options and restricted stock units could be seen as a positive sign, aligning the executive's interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding the executive's stock ownership.
Key Dates
| Date | Description |
|---|---|
| May 13, 2024 | Date of execution for the Limited Power of Attorney. |
| February 18, 2025 | Date of the reported stock transactions and grant of stock options and RSUs. |
| February 18, 2026 | First vesting date for the stock options and RSUs. |
| February 18, 2035 | Expiration date for the stock options. |
| February 20, 2025 | Date of signature for the report. |
Keywords
Form 4, insider trading, stock options, restricted stock units, WST, West Pharmaceutical Services, Annette Favorite, Section 16(a)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.